The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain

Parkinson’s Disease (PD) is the second most common neurodegenerative disease worldwide, affecting 1 % of the population over 65 years of age. Dopaminergic cell death in the substantia nigra and accumulation of Lewy bodies are the defining neuropathological hallmarks of the disease. Neuronal death an...

Descripción completa

Detalles Bibliográficos
Autores principales: Normando, Eduardo Maria, Davis, Benjamin Michael, De Groef, Lies, Nizari, Shereen, Turner, Lisa A., Ravindran, Nivedita, Pahlitzsch, Milena, Brenton, Jonathan, Malaguarnera, Giulia, Guo, Li, Somavarapu, Satyanarayana, Cordeiro, Maria Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989531/
https://www.ncbi.nlm.nih.gov/pubmed/27535749
http://dx.doi.org/10.1186/s40478-016-0346-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989531/
https://www.ncbi.nlm.nih.gov/pubmed/27535749
http://dx.doi.org/10.1186/s40478-016-0346-z

Ejemplares similares